NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 50 filers reported holding NEURODERM LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $12,673,000 | +51.6% | 325,780 | +16.5% | 0.14% | +38.5% |
| Q2 2017 | $8,359,000 | +19.1% | 279,555 | +5.8% | 0.10% | +8.3% |
| Q1 2017 | $7,017,000 | -0.4% | 264,296 | -16.7% | 0.10% | -13.5% |
| Q4 2016 | $7,047,000 | +46.2% | 317,411 | +21.8% | 0.11% | +26.1% |
| Q3 2016 | $4,820,000 | +66.1% | 260,682 | +46.0% | 0.09% | +49.2% |
| Q2 2016 | $2,902,000 | +29.1% | 178,603 | +12.2% | 0.06% | +18.0% |
| Q1 2016 | $2,247,000 | +0.6% | 159,170 | +21.5% | 0.05% | -18.0% |
| Q4 2015 | $2,233,000 | -13.1% | 130,972 | +5.4% | 0.06% | -12.9% |
| Q3 2015 | $2,569,000 | – | 124,290 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |